Sujana Chandrasekhar, MD
Otology & Neurotology · New York, NYNPI 1649363151
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,028 of the $5,228 with a category attached, or 77.0%. 32 manufacturers reported payments, led by Cochlear Americas at 34.8% of the total. Reporting peaked in 2021 at $1,518 and has fallen 50.6% since, to $750 in 2025.
Across 114 payments — averaging $45.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$2K
- GSK$457
- Phathom Pharmaceuticals, Inc.$304
- Acclarent, Inc$294
- Sanofi$288
- AstraZeneca$250
- plus $2K from 26 others
What the payments were for
- Consulting fees$1,20023%
- Food & beverage$4,02877%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 10 | $1,819 |
| GSK | 22 | $457 |
| Phathom Pharmaceuticals, Inc. | 6 | $304 |
| Acclarent, Inc | 4 | $294 |
| Sanofi | 9 | $288 |
| AstraZeneca | 2 | $250 |
| Optinose US, Inc. | 13 | $243 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $150 |
| Kerecis Limited | 1 | $143 |
| Stryker | 4 | $130 |
| Jazz Pharmaceuticals Inc. | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Regeneron | 1 | $121 |
| Hikma Pharmaceuticals USA | 5 | $118 |
| Kaleo, Inc. | 5 | $91 |
| Alk-abello, Inc | 5 | $80 |
| Arcutis Biotherapeutics, Inc. | 1 | $60 |
| Cook Medical LLC | 2 | $54 |
| Smith+Nephew | 2 | $51 |
| Novartis | 2 | $50 |
| Olympus America Inc. | 1 | $30 |
| Resmed Corp | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Itamar Medical Inc | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Circassia Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| CSL Behring | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$1,334
- Baha BI300 implant 4 mm$1,200
- Cochlear Osia OSI200 Implant$1,200
- TruDi Navigation System$485
- Kerecis Omega3 SurgiClose$428
- VOQUEZNA$250
- DUPIXENT$246
- NEFFY$150
- Kerecis Omega3 GraftGuide$143
- Kerecis Omega3 Marigen$143
- Baha$134
- OSIA OSI300 IMPLANT$134
- FASENRA$125
- TEZSPIRE$125
- NUCALA$125
- TruDi$121
- TruDi Nav Cable$118
- Relieva Tract$118
How this compares
$5,228 in reported general payments places this provider in the 65th percentile of 26 otology & neurotology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,314 |
| Ondansetron OdtOndansetron | 41 | $1,189 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 120 | $1,011 |
| Clonazepam | 34 | $622 |
| Acetazolamide | 11 | $557 |
| Fluocinolone Acetonide Oil | 14 | $378 |
| Meclizine Hcl | 25 | $355 |
| Diazepam | 31 | $241 |
| Potassium Chloride | 12 | $210 |
| Hydrochlorothiazide | 31 | $135 |
| Furosemide | 14 | $82 |
| Prednisone | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in New York
- John RolandNew York$86K
- Sean McMenomeyNew York$27K
- Daniel JethanamestNew York$17K
- Zachary SchwamNew York$15K
- David FriedmannNew York$11K
- George AlexiadesNew York$8K
- Eric SmouhaNew York$5K
- Darius KohanNew York$3K
- Neil SperlingNew York$2K
- Won Taek ChoeNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.